Jan 27, 2023
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.35 to $3.53.
The split itself did not change the total investment value.
Marker Therapeutics, Inc. (NASDAQ:MRKR) operates in the Biotechnology industry.
Marker Therapeutics, Inc. company overviewMarker Therapeutics, Inc.'s most recent stock split was on January 27, 2023. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
Marker Therapeutics, Inc. (NASDAQ:MRKR) has split its stock 6 times: a 1-for-50 reverse split on June 8, 2001, a 2-for-5 reverse split on June 28, 2007, a 1-for-10 reverse split on July 31, 2009, a 1-for-100 reverse split on February 25, 2014, a 1-for-12 reverse split on September 16, 2016, and a 1-for-10 reverse split on January 27, 2023.
Marker Therapeutics, Inc. has split its stock 6 times. This history records 6 reverse splits between June 8, 2001 and January 27, 2023.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Marker Therapeutics, Inc.'s 1-for-10 reverse split on January 27, 2023, every 10 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Marker Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on January 27, 2023, 3 years ago. Companies announce splits in advance, and any new NASDAQ:MRKR split will appear on this page.